Pentavalent Vaccine
Despite Gates’s victory in winning recommendations for Hib and hepatitis B in Asia, actual uptake rates disappointed the pharma mikados. Defying the WHO and Indian Health Ministry recommendations, local physicians stonewalled the jab. Most Indians had never heard of either illness. Dr. Puliyel told me, “Indian doctors were not impressed by the need for either Hib or hepatitis B jabs and seldom recommended them to patients.” Physician resistance stymied Indian health officials from meeting WHO’s uptake metrics for the newly recommended shots. To overcome this problem, Pharma introduced a diabolically cunning strategy to euthanize three birds with one stone. The companies withdrew their flagging Hib and hepatitis B vaccines and reissued a new concoction that combined those immunizations with the DTP, which, despite its popularity, had become another sandbag on Big Pharma’s profit ambitions.
By 2008, Pfizer’s DTP patent was long expired, and there were sixty-three manufacturers making the vaccine in forty-two countries with large surpluses and very low margins. The Gates cabal solved these profiteering problems by brewing up a new (five diseases) vaccine by mixing the DTP, Hib, and hepatitis B formulas in a single syringe. That new combination became a “new vaccine.” The Global Alliance for Vaccines and Immunizations (GAVI) and WHO christened the novel, untested, and unlicensed concoction the “Pentavalent Vaccine” and recommended its use in developing countries to replace the DTP vaccine. Compliant Indian health ministries then phased out the DTP, which had been popular with doctors. Now, if any physician or individual wanted DTP, their only choice would be the Pentavalent vaccine.
On its website, GAVI admitted that its underlying reason for this caper was to increase the uptake of the hepatitis B and Hib vaccines in these countries by piggybacking on the well-accepted DTP vaccine. It was an ingenious moneymaking connivance. Competition had driven down the cost of the DTP to 15.50 rupees—about 14 cents US. The hepatitis B vaccine retailed for 45 rupees and the Hib for 25. Therefore, the combined cost of all three vaccines if purchased separately was Rs 185. However, the new pentavalent vaccine—made by Gates’s friend Cyrus Poonawalla, owner of the Serum Institute of India—costs Rs 550, a 1,440 percent increase in profits for every vaccine sold!196
The Food and Drug Administration (FDA) has not licensed the combination vaccine for either safety or efficacy, and developed countries do not use it. A Cochrane meta-analysis showed that the combination is less effective than the vaccines given separately. Furthermore, the pentavalent vaccine is life-threatening to infants.
Before its Indian debut, Bhutan, Sri Lanka, Pakistan, and Vietnam previewed the pentavalent jab. In each of these countries, unexplained deaths followed immunization. Bhutan suspended the immunization program in October 2009 after five cases of encephalopathy/encephalitis occurred following the vaccine. WHO persuaded health officials to resume the program, insisting that viral meningoencephalitis caused the deaths. Bhutan obeyed and four infants died. Bhutan no longer uses the pentavalent vaccine. The director of Public Health, Dr. Ugen Dophu, observes that there have been no more cases of meningoencephalitis among infants after the vaccine was withdrawn.197
Sri Lanka unleashed the pentavalent vaccine in January 2008 and then suspended the program four months later after five babies died. Under pressure from WHO, Sri Lanka reintroduced the vaccine in 2010. Between 2010 and 2012, there were fourteen additional deaths following the vaccine, making the total number of deaths in Sri Lanka nineteen.198
Vietnam introduced the pentavalent jab in June 2010 and suspended the jab in May 2013, after twenty-seven infant deaths.199
The experience in Pakistan was similar, including at least three reported deaths.200
India introduced pentavalent vaccine in December 2011. Up to the first quarter of 2013, health officials reported eighty-three serious Adverse Events Following Immunization (AEFI). Twenty-one babies have died in India following immunization with the pentavalent vaccine.201
Gates and WHO simply trivialize the deaths as sad coincidences or collateral damage. The vaccine has effectively reduced the incidence of Hib disease in India. However, there has been a proportionate increase in non-Hib strains of H. influenzae, including non-serotypable strains, causing invasive disease in the post-Hib vaccine era. As usual, there was no accounting.
This is only one of many examples of the Gates Foundation prioritizing the mandate for high-cost vaccines in the national immunization programs that Bill Gates effectively controls. Putting aside questions about net costs and benefits from these dangerous jabs, McGoey agrees with Puliyel that the diversion of sanitation and nutrition money is also deadly: “The problem is that by prioritizing the delivery of expensive vaccines, other proven interventions lose out.”202
Real-world evidence, including his investments in pharmaceutical, petroleum, chemical, and GMO, processed, and synthetic food, suggests that Gates’s obsession with vaccines does not evince any genuine commitment to healthy populations. According to Amy Goodman, Gates owns investments in sixty-nine of the world’s worst-polluting companies.203 His single-minded obsession with vaccines seems to serve his impulse to monetize his charity and to achieve monopoly control over global public health policy. His strategies and corporate alliances in the food, public health, and education sectors may also reflect messianic conviction that he is ordained to save the world with technology, top-down centralized cookie-cutter solutions to complex human problems, and a godlike willingness to experiment with the lives of lesser humans.
And Gates’s vaccine cartel has amassed Midas-like riches. Early in 2021, a TV interviewer, Becky Quick, observed that Gates had spent $10 billion on vaccines over the past two decades and asked Gates, “You’ve figured out the return on investment for that and it kind of stunned me. Can you walk us through the math?” Gates responded: “We see a phenomenal track record . . . there’s been over a 20-to-1 return. So if you just looked at the economic benefits, that’s a pretty strong number.” The interviewer pressed him: “If you had put that money into an S&P 500 and reinvested the dividends, you’d come up with something like $17 billion dollars, but you think it’s $200 billion dollars.” Gates continued: “Here, yeah,” hastening to add that “helping young children live, get the right nutrition, contribute to their countries, that has a payback that goes beyond any typical financial return.”204
The key to it all, he added, is “Having that big portfolio.”
And the key to much of that portfolio is having Anthony Fauci.
Endnotes